Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3309)
All Articles published online
|
Jul 7, 2009 (publication date) through May 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abu-Hilal M, Tawaker J. Portal hypertension secondary to myelofibrosis with myeloid metaplasia: A study of 13 cases. World J Gastroenterol 2009; 15(25): 3128-3133 [PMID: 19575492 DOI: 10.3748/wjg.15.3128] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i25/3128.htm |
| Number | Citing Articles |
| 1 |
Kohtaro Toyama, Takeki Mitsui, Akihiko Yokohama, Takayuki Saitoh, Hideki Uchiumi, Hiroshi Handa, Masataka Sakuraya, Hirokazu Murakami, Yoshihisa Nojima, Norifumi Tsukamoto. Polycythemia Vera Terminating in Refractory Ascites. The Kitakanto Medical Journal 2012; 62(2): 159 doi: 10.2974/kmj.62.159
|
| 2 |
Ahmet Burak Toros, Serkan Gokcay, Guven Cetin, Muhlis Cem Ar, Yesim Karagoz, Besir Kesici. Portal Hypertension and Myeloproliferative Neoplasms: A Relationship Revealed. ISRN Hematology 2013; 2013: 1 doi: 10.1155/2013/673781
|
| 3 |
S. Rajesh, Amar Mukund, Binit Sureka, Kalpana Bansal, Maxime Ronot, Ankur Arora. Non-cirrhotic portal hypertension: an imaging review. Abdominal Radiology 2018; 43(8): 1991 doi: 10.1007/s00261-018-1570-8
|
| 4 |
Ananya Panda, Sheragaru Hanumanthappa Chandrashekhara, Aruna Nambirajan, Pravas Mishra. Idiopathic myelofibrosis with disseminated hepatosplenic, mesenteric, renal and pulmonary extramedullary haematopoeisis, portal hypertension and tuberculosis: initial presentation and 2 years follow-up. BMJ Case Reports 2016; : bcr2016217854 doi: 10.1136/bcr-2016-217854
|
| 5 |
Yolandi Rautenbach, Amelia Goddard, Sarah J. Clift. Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog. Veterinary Clinical Pathology 2017; 46(1): 46 doi: 10.1111/vcp.12430
|
| 6 |
Debanjali Mitra, James A. Kaye, Lance T. Piecoro, Jennifer Brown, Kelly Reith, Tariq I. Mughal, Nicholas J. Sarlis. Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review. Cancer Medicine 2013; 2(6): 889 doi: 10.1002/cam4.136
|
| 7 |
Ankur Varma, Susan C. Abraham, Rohtesh S. Mehta, Neeraj Y. Saini, Medhavi Honhar, Munazza Rashid, Julianne Chen, Samer A. Srour, Qaiser Bashir, Gabriela Rondon, Betul Oran, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, David Marin, Issa F. Khouri, Stefan O. Ciurea, Muzaffar H. Qazilbash, Katy Rezvani, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Richard E. Champlin, Uday R. Popat. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Advances 2020; 4(7): 1296 doi: 10.1182/bloodadvances.2019000638
|
| 8 |
Claire Harrison, Ruben Mesa, David Ross, Adam Mead, Clodagh Keohane, Jason Gotlib, Srdan Verstovsek. Practical management of patients with myelofibrosis receiving ruxolitinib. Expert Review of Hematology 2013; 6(5): 511 doi: 10.1586/17474086.2013.827413
|
| 9 |
Dimitrios N Samonakis, Aikaterini Mantaka,, Dimitrios Tsetis,, Adam Hatzidakis, Elias A Kouroumalis. Successful management of refractory gastric variceal bleeding via a combined percutaneous approach in sinistral portal hypertension. Gastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00294
|
| 10 |
Marco Casaccia, Rosario Fornaro, Marco Frascio, Denise Palombo, Cesare Stabilini, Emma Firpo, Ezio Gianetta. Peritoneal carcinomatosis-like implants of extramedullary hematopoiesis. An insolite occurrence during splenectomy for myelofibrosis. International Journal of Surgery Case Reports 2017; 41: 9 doi: 10.1016/j.ijscr.2017.09.030
|
| 11 |
Kit Man Wong, Eshetu G. Atenafu, Dennis Kim, John Kuruvilla, Jeffrey H. Lipton, Hans Messner, Vikas Gupta. Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 2012; 18(10): 1589 doi: 10.1016/j.bbmt.2012.04.011
|
| 12 |
Xiu-Qing Wei, Zong-Heng Zheng, Yi Jin, Jin Tao, Kodjo-Kunale Abassa, Zhuo-Fu Wen, Chun-Kui Shao, Hong-Bo Wei, Bin Wu. Intestinal obstruction caused by extramedullary hematopoiesis and ascites in primary myelofibrosis. World Journal of Gastroenterology 2014; 20(33): 11921-11926 doi: 10.3748/wjg.v20.i33.11921
|
| 13 |
Douglas Motomura, Tasha Kulai, Ian Epstein. Esophageal Variceal Hemorrhage Secondary to Post-Polycythemic Myelofibrosis. Journal of the Canadian Association of Gastroenterology 2018; 1(3): 95 doi: 10.1093/jcag/gwy016
|
| 14 |
Ken Ogasawara, William B. Smith, Christine Xu, Jian Yin, Maria Palmisano, Gopal Krishna. Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment. Cancer Chemotherapy and Pharmacology 2020; 85(6): 1109 doi: 10.1007/s00280-020-04084-2
|
| 15 |
Splenomegaly Secondary to Myeloproliferative Neoplasms and Portal Hypertension. Clinical Lymphoma Myeloma and Leukemia 2015; 15(6): e135 doi: 10.1016/j.clml.2014.10.005
|
| 16 |
Rinkle R Gemnani, Avinash Parepalli, Sunil Kumar, Sourya Acharya, Samarth Shukla. Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension. Cureus 2023; doi: 10.7759/cureus.40692
|
| 17 |
Fabio P. S. Santos, Constantine S. Tam, Hagop Kantarjian, Jorge Cortes, Deborah Thomas, Raphael Pollock, Srdan Verstovsek. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leukemia & Lymphoma 2014; 55(1): 121 doi: 10.3109/10428194.2013.794269
|
| 18 |
R. Ennaifer, M. Sabbah, R. Hefaiedh, H. Romdhane, N. Bel Hadj. Exudative ascites as presenting manifestation of latent essential thrombocytemia. JCC Open 2013; 1(1): 4 doi: 10.1016/j.jcco.2012.11.001
|
| 19 |
Hidetaka Hamasaki, Shuichi Mishima, Hidekatsu Yanai. Hyperinsulinemia and insulin resistance in a patient with type 2 diabetes complicated with myelofibrosis. World Journal of Diabetes 2012; 3(8): 156-157 doi: 10.4239/wjd.v3.i8.156
Abstract(750) |
Core Tip(646) |
Full Article(HTML)(2151)
|
Full Article (PDF)-486K(259)
|
Times Cited (0)
|
Total Visits (3941)
|
Open
|
| 20 |
Xiu He Lv, Liang Liang Ma, Wei Yun Fu, Yan Xie. Splenic marginal zone lymphoma leads to sinistral portal hypertension. Journal of Digestive Diseases 2019; 20(1): 45 doi: 10.1111/1751-2980.12696
|
| 21 |
Matthew Yan, Holly Geyer, Ruben Mesa, Ehab Atallah, Jeannie Callum, Justyna Bartoszko, Karen Yee, Manjula Maganti, Florence Wong, Vikas Gupta. Clinical Features of Patients With Philadelphia-Negative Myeloproliferative Neoplasms Complicated by Portal Hypertension. Clinical Lymphoma Myeloma and Leukemia 2015; 15(1): e1 doi: 10.1016/j.clml.2014.04.004
|
| 22 |
Sadia Sultan, Syed Mohammed Irfan. Primary Idiopathic Myelofibrosis: Clinico-Epidemiological Profile and Risk Stratification in Pakistani Patients. Asian Pacific Journal of Cancer Prevention 2016; 16(18): 8629 doi: 10.7314/APJCP.2015.16.18.8629
|
| 23 |
Takuya Kihara, Takaaki Sugihara, Suguru Ikeda, Yukako Matsuki, Takakazu Nagahara, Kenji Oyama, Jun-ichi Okano, Hajime Isomoto. A case of portal hypertension complicated with <i>de novo</i> acute myeloid leukemia. Kanzo 2022; 63(9): 409 doi: 10.2957/kanzo.63.409
|
| 24 |
J. Lemaire, A. Rosière, C. Bertrand, B. Bihin, J. E. Donckier, L. A. Michel. Surgery for massive splenomegaly. BJS Open 2017; 1(1): 11 doi: 10.1002/bjs5.1
|
| 25 |
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms. Clinical and Molecular Hepatology 2020; 26(1): 78 doi: 10.3350/cmh.2019.0078
|